All Pharma News
Japan`s Eisai developing dementia drug for US market, Nikkei reports

Japan`s Eisai developing dementia drug for US market, Nikkei reports
REUTERS
01 Jul 2024
Share Share
Ensho emerges with inflammatory disease portfolio from Eisai`s EA Pharma

Ensho emerges with inflammatory disease portfolio from Eisai`s EA Pharma
FIERCE BIOTECH
28 Jun 2024
Share Share
Lilly Alzheimer`s drug gets unanimous backing from FDA advisory panel

Lilly Alzheimer`s drug gets unanimous backing from FDA advisory panel
Bhanvi Satija REUTERS
11 Jun 2024
Share Share
FDA accepts Eisai`s monthly dosing application for Leqembi

FDA accepts Eisai`s monthly dosing application for Leqembi
Eric Sagonowsky FIERCE PHARMA
11 Jun 2024
Share Share
FDA Accepts Eisai’s Filing of LEQEMBI sBLA for IV for Early Alzheimer’s Disease

FDA Accepts Eisai’s Filing of LEQEMBI sBLA for IV for Early Alzheimer’s Disease
GLOBENEWSWIRE
07 Jun 2024
Share Share
Lilly tipped to beat Eisai, Biogen, win $13B Alzheimer`s fight

Lilly tipped to beat Eisai, Biogen, win $13B Alzheimer`s fight
Nick Paul Taylor FIERCE PHARMA
07 Jun 2024
Share Share
US FDA staff raise no major concerns about Eli Lilly Alzheimer`s drug

US FDA staff raise no major concerns about Eli Lilly Alzheimer`s drug

Bhanvi Satija REUTERS
07 Jun 2024
Share Share
Eisai`s LEQEMBI receives approval in South Korea for treatment of AD

Eisai`s LEQEMBI receives approval in South Korea for treatment of AD
BIOSPECTRUM ASIA
28 May 2024
Share Share
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024

Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
PR NEWSWIRE
23 May 2024
Share Share
Metoject subcutaneous inj pen launches in Japan rheumatic arthritis treatment

Metoject subcutaneous inj pen launches in Japan rheumatic arthritis treatment
BIOSPECTRUM ASIA
22 May 2024
Share Share